PBM

Propel Bio Management Portfolio holdings

AUM $159M
1-Year Est. Return 60.94%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+60.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$159M
AUM Growth
+$41.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$6.15M
2
+$5.53M
3
+$5.24M
4
VOR icon
Vor Biopharma
VOR
+$4.44M
5
OBIO icon
Orchestra BioMed
OBIO
+$3.82M

Top Sells

1
+$3.5M
2
+$2.15M
3
+$1.68M
4
IVA
Inventiva
IVA
+$1.68M
5
OCS icon
Oculis Holding
OCS
+$1.34M

Sector Composition

1 Healthcare 80.98%
2 Energy 19.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVID icon
26
Ovid Therapeutics
OVID
$510M
$2.04M 1.28%
+921,457
PALI icon
27
Palisade Bio
PALI
$368M
$2M 1.26%
+1,115,000
KLRS
28
Kalaris Therapeutics
KLRS
$125M
$1.72M 1.08%
295,771
+253,718
QURE icon
29
uniQure
QURE
$1.8B
$1.71M 1.08%
+104,772
LONA
30
LeonaBio Inc
LONA
$89.6M
$1.5M 0.94%
149,279
NUVB icon
31
Nuvation Bio
NUVB
$1.66B
$1.41M 0.89%
+329,296
MAZE
32
Maze Therapeutics
MAZE
$1.46B
$1.31M 0.82%
+43,798
EVMN
33
Evommune Inc
EVMN
$837M
$1.28M 0.81%
+55,664
CRVS icon
34
Corvus Pharmaceuticals
CRVS
$1.04B
$1.25M 0.79%
+85,791
ALDX icon
35
Aldeyra Therapeutics
ALDX
$106M
$1.23M 0.78%
+730,606
ARTV
36
Artiva Biotherapeutics
ARTV
$385M
$950K 0.6%
+146,369
CNTB
37
Connect Biopharma Holdings
CNTB
$157M
$554K 0.35%
+209,493
MSLE
38
Satellos Bioscience
MSLE
$152M
$57.1K 0.04%
+10,145
NKTR icon
39
Nektar Therapeutics
NKTR
$2.19B
– –
-82,822
RGNX icon
40
Regenxbio
RGNX
$362M
– –
-116,896
LENZ
41
LENZ Therapeutics
LENZ
$244M
– –
-59,085
AARD
42
Aardvark Therapeutics
AARD
$89.7M
– –
-46,408
1
2